• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Ultralife Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    7/17/25 4:16:52 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ULBI alert in real time by email
    ulbi20250717_8k.htm
    false 0000875657 0000875657 2025-07-16 2025-07-16
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    FORM 8-K
     
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
     
    July 16, 2025
    Date of Report (Date of Earliest Event Reported)
     
     
    ULTRALIFE CORPORATION
    (Exact name of registrant as specified in its charter)
     
    Delaware
    000-20852
    16-1387013
    (State of incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)
     
    2000 Technology Parkway, Newark, New York 14513
    (Address of principal executive offices) (Zip Code)
     
    (315) 332-7100
    (Registrant’s telephone number, including area code)
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Common Stock, $0.10 par value per share
    ULBI
    NASDAQ
    (Title of each class)
    (Trading Symbol)
    (Name of each exchange on which registered)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 5.07         Submission of Matters to a Vote of Security Holders.
     
    On July 16, 2025, Ultralife Corporation (“the Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Only stockholders of record at the close of business on May 22, 2025 (the “Record Date”) were entitled to vote at the Annual Meeting. As of the Record Date, there were 16,632,965 shares of common stock outstanding and entitled to vote, of which 14,196,720 (85.35%) were present in person or by proxy, representing a quorum. The results of stockholder voting on the proposals presented were as follows:
     
    1. The Company’s stockholders elected five Directors, all of whom constitute the Company’s entire Board of Directors, to serve for a term of one year and until their successors are duly elected and qualified. The number of shares that (i) voted for the election of each Director, (ii) withheld authority to vote for each Director, and (iii) were broker non-votes, are set forth in the table below.
     
    Director
    For
    Withheld
    Broker Non-Votes
           
    Michael E. Manna
    11,221,121
      35,180
    2,940,419
    Janie Goddard 10,640,750 615,551 2,940,419
    Thomas L. Saeli
    11,156,940
      99,361
    2,940,419
    Robert W. Shaw II
    11,159,610
      96,691
    2,940,419
    Bradford T. Whitmore
    10,508,532
    747,769
    2,940,419
     
     
     
    2.  The Company’s stockholders ratified the selection of the Company’s independent registered public accounting firm as Freed Maxick P.C. for 2025.  The number of shares that (i) voted for the ratification of the accounting firm, (ii) voted against the ratification, and (iii) abstained from the vote are set forth in the table below.
     
    For
    Against
    Abstain
         
    14,042,572
    61,028
    21,888
     
     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Date: July 17, 2025
     
    ULTRALIFE CORPORATION
         
         
     
    By:
    /s/ Philip A. Fain
       
    Philip A. Fain
       
    Chief Financial Officer and Treasurer
         
         
     
     
    Get the next $ULBI alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ULBI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ULBI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ultralife Corporation Reports First Quarter Results

      NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for Batteries & Energy Products and a 36.2% decrease in Communications Systems salesGross profit of $12.7 million, or 25.1% of revenue, compared to $11.5 million, or 27.4% of revenue, for the 2024 first quarterOperating income of $3.4 million, including one-time non-recurring costs and purchase accounting adjustments of $0.4 million, compared to $4.1 million for the 2024 first quarterGAAP EPS of $0.11 comp

      5/9/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation to Report First Quarter Results on May 9, 2025

      NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on May 9, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI00ee37974c5b4cbc86cd1d7ef099d998. This will e

      4/29/25 9:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports Fourth Quarter Results

      Acquisition of Electrochem Completed and Integration Has Commenced                 NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems salesGross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarterOperating income of $1.5 million, including one-time costs and GAAP adjustments of

      4/1/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Whitmore Bradford T bought $76,392 worth of shares (10,000 units at $7.64) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      6/13/25 4:19:24 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Goddard Janie bought $11,889 worth of Common Stock; $.10 par value (1,548 units at $7.68), increasing direct ownership by 35% to 5,929 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      6/13/25 3:09:28 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Whitmore Bradford T bought $64,778 worth of shares (11,980 units at $5.41) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/28/25 4:16:03 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    SEC Filings

    See more
    • Ultralife Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ULTRALIFE CORP (0000875657) (Filer)

      7/17/25 4:16:52 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SD filed by Ultralife Corporation

      SD - ULTRALIFE CORP (0000875657) (Filer)

      5/28/25 8:56:13 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form DEFA14A filed by Ultralife Corporation

      DEFA14A - ULTRALIFE CORP (0000875657) (Filer)

      5/27/25 1:04:07 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Benchmark initiated coverage on Ultralife with a new price target

      Benchmark initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

      3/26/21 8:30:50 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • The Benchmark Company initiated coverage on Ultralife with a new price target

      The Benchmark Company initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

      3/26/21 7:38:12 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Whitmore Bradford T bought $76,392 worth of shares (10,000 units at $7.64) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      6/13/25 4:19:24 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Goddard Janie bought $11,889 worth of Common Stock; $.10 par value (1,548 units at $7.68), increasing direct ownership by 35% to 5,929 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      6/13/25 3:09:28 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Whitmore Bradford T bought $64,778 worth of shares (11,980 units at $5.41) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/28/25 4:16:03 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Ultralife Corporation

      SC 13D/A - ULTRALIFE CORP (0000875657) (Subject)

      9/3/24 4:15:14 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G filed by Ultralife Corporation

      SC 13G - ULTRALIFE CORP (0000875657) (Subject)

      2/14/24 1:50:40 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Ultralife Corporation (Amendment)

      SC 13G/A - ULTRALIFE CORP (0000875657) (Subject)

      2/9/24 9:59:17 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Leadership Updates

    Live Leadership Updates

    See more
    • Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans

      NEWARK, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing our corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with our sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife's products and solutions meet the evolving needs of our customers. Jeff brings over two

      1/6/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Names Michael E. Manna President & CEO

      NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation ("Ultralife" or the "Company") (NASDAQ:ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO. "Over the past twe

      11/22/22 4:30:00 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Financials

    Live finance-specific insights

    See more
    • Ultralife Corporation Reports First Quarter Results

      NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for Batteries & Energy Products and a 36.2% decrease in Communications Systems salesGross profit of $12.7 million, or 25.1% of revenue, compared to $11.5 million, or 27.4% of revenue, for the 2024 first quarterOperating income of $3.4 million, including one-time non-recurring costs and purchase accounting adjustments of $0.4 million, compared to $4.1 million for the 2024 first quarterGAAP EPS of $0.11 comp

      5/9/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation to Report First Quarter Results on May 9, 2025

      NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on May 9, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI00ee37974c5b4cbc86cd1d7ef099d998. This will e

      4/29/25 9:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports Fourth Quarter Results

      Acquisition of Electrochem Completed and Integration Has Commenced                 NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems salesGross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarterOperating income of $1.5 million, including one-time costs and GAAP adjustments of

      4/1/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous